
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 53429
[patent_doc_number] => 07772282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Synergistic insecticidal compositions'
[patent_app_type] => utility
[patent_app_number] => 11/930821
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4565
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772282.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930821 | Synergistic insecticidal compositions | Oct 30, 2007 | Issued |
Array
(
[id] => 4944470
[patent_doc_number] => 20080081796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'TREATMENT OF MUCOSITIS'
[patent_app_type] => utility
[patent_app_number] => 11/931613
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7877
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081796.pdf
[firstpage_image] =>[orig_patent_app_number] => 11931613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/931613 | TREATMENT OF MUCOSITIS | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4833951
[patent_doc_number] => 20080132498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'SYNERGISTIC INSECTICIDAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/930344
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4576
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930344
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930344 | Synergistic insecticidal compositions | Oct 30, 2007 | Issued |
Array
(
[id] => 5331398
[patent_doc_number] => 20090111875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Skin care compositions'
[patent_app_type] => utility
[patent_app_number] => 11/978338
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7255
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978338
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978338 | Skin care compositions | Oct 28, 2007 | Abandoned |
Array
(
[id] => 4916231
[patent_doc_number] => 20080096832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Method for Improving the Pharmacokinetics of an NNRTI'
[patent_app_type] => utility
[patent_app_number] => 11/923699
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4111
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11923699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/923699 | Method for Improving the Pharmacokinetics of an NNRTI | Oct 24, 2007 | Abandoned |
Array
(
[id] => 4826849
[patent_doc_number] => 20080125393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Methods of selectively treating diseases with specific glycosaminoglycan polymers'
[patent_app_type] => utility
[patent_app_number] => 11/977131
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 31085
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11977131
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/977131 | Methods of selectively treating diseases with specific glycosaminoglycan polymers | Oct 22, 2007 | Abandoned |
Array
(
[id] => 221092
[patent_doc_number] => 07608638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/876612
[patent_app_country] => US
[patent_app_date] => 2007-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 26188
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11876612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/876612 | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof | Oct 21, 2007 | Issued |
Array
(
[id] => 6616524
[patent_doc_number] => 20100323984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'COSMETIC ORAL AND/OR PARENTERAL USE OF GLUCOSAMINE OPTIONALLY IN COMBINATION WITH AT LEAST ONE POLYPHENOL COMPOUND, AND CORRESPONDING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/445960
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12442
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0323/20100323984.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445960
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445960 | COSMETIC ORAL AND/OR PARENTERAL USE OF GLUCOSAMINE OPTIONALLY IN COMBINATION WITH AT LEAST ONE POLYPHENOL COMPOUND, AND CORRESPONDING COMPOSITION | Oct 18, 2007 | Abandoned |
Array
(
[id] => 4704497
[patent_doc_number] => 20080064021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity'
[patent_app_type] => utility
[patent_app_number] => 11/975072
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16222
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064021.pdf
[firstpage_image] =>[orig_patent_app_number] => 11975072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/975072 | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity | Oct 16, 2007 | Issued |
Array
(
[id] => 6295319
[patent_doc_number] => 20100160246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'MICROSPHERES FOR TREATMENT OF BRAIN TUMORS'
[patent_app_type] => utility
[patent_app_number] => 12/089797
[patent_app_country] => US
[patent_app_date] => 2007-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12694
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160246.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089797 | Microspheres for treatment of brain tumors | Oct 9, 2007 | Issued |
Array
(
[id] => 4746172
[patent_doc_number] => 20080090774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations'
[patent_app_type] => utility
[patent_app_number] => 11/906665
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30646
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11906665
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/906665 | Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations | Oct 1, 2007 | Abandoned |
Array
(
[id] => 4704168
[patent_doc_number] => 20080063692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Isomaltooligosaccharides to Inhibit Avian Pathogenic Intestinal Bacteria'
[patent_app_type] => utility
[patent_app_number] => 11/862499
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9931
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862499
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862499 | Isomaltooligosaccharides to inhibit avian pathogenic intestinal bacteria | Sep 26, 2007 | Issued |
Array
(
[id] => 43196
[patent_doc_number] => 07781577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Inhibitors of sodium glucose co-transporter 2 and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 11/862690
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23551
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781577.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862690 | Inhibitors of sodium glucose co-transporter 2 and methods of their use | Sep 26, 2007 | Issued |
Array
(
[id] => 4705134
[patent_doc_number] => 20080064658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Use of Isomaltooligosaccharides to Decrease Abdominal Fat'
[patent_app_type] => utility
[patent_app_number] => 11/861667
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9933
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11861667
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/861667 | Use of Isomaltooligosaccharides to Decrease Abdominal Fat | Sep 25, 2007 | Abandoned |
Array
(
[id] => 4682838
[patent_doc_number] => 20080249064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same'
[patent_app_type] => utility
[patent_app_number] => 11/902836
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3336
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11902836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/902836 | Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same | Sep 25, 2007 | Abandoned |
Array
(
[id] => 4705133
[patent_doc_number] => 20080064657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Isomaltooligosaccharides from Leuconostoc as Neutraceuticals'
[patent_app_type] => utility
[patent_app_number] => 11/860845
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9926
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11860845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/860845 | Isomaltooligosaccharides from Leuconostoc as Neutraceuticals | Sep 24, 2007 | Abandoned |
Array
(
[id] => 5398309
[patent_doc_number] => 20090318372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside'
[patent_app_type] => utility
[patent_app_number] => 12/442288
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6074
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318372.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442288
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442288 | Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside | Sep 20, 2007 | Abandoned |
Array
(
[id] => 4939414
[patent_doc_number] => 20080076733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin'
[patent_app_type] => utility
[patent_app_number] => 11/903066
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17413
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076733.pdf
[firstpage_image] =>[orig_patent_app_number] => 11903066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/903066 | Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin | Sep 19, 2007 | Issued |
Array
(
[id] => 5398321
[patent_doc_number] => 20090318384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/441808
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2895
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318384.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441808 | COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Sep 16, 2007 | Abandoned |
Array
(
[id] => 4933462
[patent_doc_number] => 20080004237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers'
[patent_app_type] => utility
[patent_app_number] => 11/657754
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7172
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11657754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/657754 | Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers | Sep 16, 2007 | Abandoned |